(Q39923515)

English

Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways (English)

1 reference

Europe PubMed Central

15 September 2017

author name string

Keun-Gyu Park

1

1 reference

Europe PubMed Central

15 September 2017

Ae-Kyung Min

2

1 reference

Europe PubMed Central

15 September 2017

Eun Hee Koh

3

1 reference

Europe PubMed Central

15 September 2017

Hyoun Sik Kim

4

1 reference

Europe PubMed Central

15 September 2017

Mi-Ok Kim

5

1 reference

Europe PubMed Central

15 September 2017

Hye-Sun Park

6

1 reference

Europe PubMed Central

15 September 2017

Yong-Deuk Kim

7

1 reference

Europe PubMed Central

15 September 2017

Tae-Seung Yoon

8

1 reference

Europe PubMed Central

15 September 2017

Byoung Kuk Jang

9

1 reference

Europe PubMed Central

15 September 2017

Jae Seok Hwang

10

1 reference

Europe PubMed Central

15 September 2017

Jae Bum Kim

11

1 reference

Europe PubMed Central

15 September 2017

Hueng-Sik Choi

12

1 reference

Europe PubMed Central

15 September 2017

Joong-Yeol Park

13

1 reference

Europe PubMed Central

15 September 2017

In-Kyu Lee

14

1 reference

Europe PubMed Central

15 September 2017

Ki-Up Lee

15

1 reference

Europe PubMed Central

15 September 2017

language of work or name

0 references

publication date

1 November 2008

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

48

1 reference

Europe PubMed Central

15 September 2017

5

1 reference

Europe PubMed Central

15 September 2017

1477-1486

1 reference

Europe PubMed Central

15 September 2017

Liver pathology and the metabolic syndrome X in severe obesity.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Weight-reducing effects of the plasma protein encoded by the obese gene

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Expression of the rat sterol regulatory element-binding protein-1c gene in response to insulin is mediated by increased transactivating capacity of specificity protein 1 (Sp1).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Alpha-lipoic acid prevents lipotoxic cardiomyopathy in acyl CoA-synthase transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Liver X receptors as integrators of metabolic and inflammatory signaling

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

21 January 2018

Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

α-Lipoic acid regulates AMP-activated protein kinase and inhibits insulin secretion from beta cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-lipoic acid inhibits glycogen synthesis in rat soleus muscle via its oxidative activity and the uncoupling of mitochondria.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.22496

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39923515&oldid=1878673391"